MGNet: Assessing High-Dose Chemotherapy and Hematopoietic Cell Transplantation in Severe Myasthenia Gravis
14 nov 2023 ·
1 min. 59 sec.
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal Annals of Clinical and Translational Neurology on September 19,...
mostra di più
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal Annals of Clinical and Translational Neurology on September 19, 2023, titled "Remission of severe myasthenia gravis after autologous stem cell transplantation."
Read the paper here: https://onlinelibrary.wiley.com/doi/10.1002/acn3.51898
Learn more about MGNet: https://mgnet.rarediseasesnetwork.org
mostra meno
Read the paper here: https://onlinelibrary.wiley.com/doi/10.1002/acn3.51898
Learn more about MGNet: https://mgnet.rarediseasesnetwork.org
Informazioni
| Autore | RDCRN |
| Organizzazione | RDCRN |
| Sito | - |
| Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Commenti